These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28318897)

  • 1. Efficacy of off-label augmentation in unipolar depression: A systematic review of the evidence.
    Kleeblatt J; Betzler F; Kilarski LL; Bschor T; Köhler S
    Eur Neuropsychopharmacol; 2017 May; 27(5):423-441. PubMed ID: 28318897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of augmentation strategies for patients with major depressive disorder.
    Fleurence R; Williamson R; Jing Y; Kim E; Tran QV; Pikalov AS; Thase ME
    Psychopharmacol Bull; 2009; 42(3):57-90. PubMed ID: 19752841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of adding nutritional supplements in unipolar depression: A systematic review and meta-analysis.
    Schefft C; Kilarski LL; Bschor T; Köhler S
    Eur Neuropsychopharmacol; 2017 Nov; 27(11):1090-1109. PubMed ID: 28988944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].
    Erbe S; Gutwinski S; Bschor T
    Psychiatr Prax; 2012 Mar; 39(2):57-63. PubMed ID: 22189902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications.
    Zhang MW; Harris KM; Ho RC
    BMC Med Ethics; 2016 Jan; 17():4. PubMed ID: 26768892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression.
    Nelson JC; Baumann P; Delucchi K; Joffe R; Katona C
    J Affect Disord; 2014 Oct; 168():269-75. PubMed ID: 25069082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of standard depression therapy.
    Marangell LB
    Clin Ther; 2000; 22 Suppl A():A25-38; discussion A39-41. PubMed ID: 10815648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants.
    Bauer M; Adli M; Bschor T; Pilhatsch M; Pfennig A; Sasse J; Schmid R; Lewitzka U
    Neuropsychobiology; 2010; 62(1):36-42. PubMed ID: 20453533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Augmentation strategies for therapy resistant depression - a review].
    Schmauss M; Messer T
    Psychiatr Prax; 2007 May; 34(4):165-74. PubMed ID: 17160747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation strategies for treatment-resistant depression: a literature review.
    Carvalho AF; Cavalcante JL; Castelo MS; Lima MC
    J Clin Pharm Ther; 2007 Oct; 32(5):415-28. PubMed ID: 17875106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B; Alevizos E; Leonardou A; Zervas I
    Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination therapies in antidepressive drug refractory depression--an overview].
    Schmauss M; Erfurth A
    Fortschr Neurol Psychiatr; 1996 Oct; 64(10):390-402. PubMed ID: 9036099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of atypical antipsychotics in refractory depression and anxiety.
    Nemeroff CB
    J Clin Psychiatry; 2005; 66 Suppl 8():13-21. PubMed ID: 16336032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium augmentation in refractory depression.
    Katona CL
    Psychiatr Dev; 1988; 6(2):153-71. PubMed ID: 3070547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.
    Ivković M; Damjanović A; Jovanović A; Cvetić T; Jasović-Gasić M
    Psychiatr Danub; 2009 Jun; 21(2):187-93. PubMed ID: 19556947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression.
    Bauer M; Bschor T; Kunz D; Berghöfer A; Ströhle A; Müller-Oerlinghausen B
    Am J Psychiatry; 2000 Sep; 157(9):1429-35. PubMed ID: 10964859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.